BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19357310)

  • 1. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
    Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
    J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
    Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
    Lee CW; Ferreon JC; Ferreon AC; Arai M; Wright PE
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19290-5. PubMed ID: 20962272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.
    Lee CW; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2010 Nov; 49(46):9964-71. PubMed ID: 20961098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
    Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
    Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
    Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
    Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
    J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.
    Teufel DP; Bycroft M; Fersht AR
    Oncogene; 2009 May; 28(20):2112-8. PubMed ID: 19363523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
    Teufel DP; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
    Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain.
    Goto NK; Zor T; Martinez-Yamout M; Dyson HJ; Wright PE
    J Biol Chem; 2002 Nov; 277(45):43168-74. PubMed ID: 12205094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of multisite protein-ligand interactions by NMR: binding of intrinsically disordered p53 transactivation subdomains with the TAZ2 domain of CBP.
    Arai M; Ferreon JC; Wright PE
    J Am Chem Soc; 2012 Feb; 134(8):3792-803. PubMed ID: 22280219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.
    Feng H; Jenkins LM; Durell SR; Hayashi R; Mazur SJ; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Bai Y
    Structure; 2009 Feb; 17(2):202-10. PubMed ID: 19217391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein.
    Liu G; Xia T; Chen X
    J Biol Chem; 2003 May; 278(19):17557-65. PubMed ID: 12609999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared structural features of the 9aaTAD family in complex with CBP.
    Piskacek M; Vasku A; Hajek R; Knight A
    Mol Biosyst; 2015 Mar; 11(3):844-51. PubMed ID: 25564305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53.
    Borger DR; DeCaprio JA
    J Virol; 2006 May; 80(9):4292-303. PubMed ID: 16611888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
    Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.
    Shi D; Pop MS; Kulikov R; Love IM; Kung AL; Grossman SR
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16275-80. PubMed ID: 19805293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.